These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 30786974

  • 1. A Comparison of Clinical Outcomes Following Femoropopliteal Bypass or Plain Balloon Angioplasty with Selective Bare Metal Stenting in the Bypass Versus Angioplasty in Severe Ischaemia of the Limb (BASIL) Trial.
    Meecham L, Bate G, Patel S, Bradbury AW.
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):52-59. PubMed ID: 30786974
    [Abstract] [Full Text] [Related]

  • 2. Editor's Choice - Relationship Between Global Limb Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial.
    Kodama A, Meecham L, Popplewell M, Bate G, Conte MS, Bradbury AW.
    Eur J Vasc Endovasc Surg; 2020 Nov; 60(5):687-695. PubMed ID: 32778491
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of femoropopliteal plain balloon angioplasty for chronic limb-threatening ischemia in the BASIL trial and in a UK contemporary series.
    Meecham L, Popplewell M, Bate G, Patel S, Bradbury AW.
    J Vasc Surg; 2021 Dec; 74(6):1948-1955. PubMed ID: 34298121
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Contemporary (2009-2014) clinical outcomes after femoropopliteal bypass surgery for chronic limb threatening ischemia are inferior to those reported in the UK Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) trial (1999-2004).
    Meecham L, Popplewell M, Bate G, Patel S, Bradbury AW.
    J Vasc Surg; 2019 Jun; 69(6):1840-1847. PubMed ID: 30852037
    [Abstract] [Full Text] [Related]

  • 8. Vein bypass first vs. best endovascular treatment first revascularisation strategy for chronic limb-threatening ischaemia due to infra-popliteal disease: the BASIL-2 RCT.
    Moakes CA, Bradbury AW, Abdali Z, Bate GR, Hall J, Jarrett H, Kelly L, Kigozi J, Lockyer S, Meecham L, Patel S, Popplewell M, Slinn G, Deeks JJ, BASIL-2 Investigators.
    Health Technol Assess; 2024 Oct; 28(65):1-72. PubMed ID: 39397484
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of Immediate and Long-term Outcomes in Men and Women Undergoing Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL-1) Trial.
    Benson RA, Meecham LA, Hewitt CA, Bradbury AW.
    Eur J Vasc Endovasc Surg; 2019 Aug; 58(2):224-228. PubMed ID: 31201136
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Long Term Outcomes After Endovascular Treatment Versus Bypass Surgery in Chronic Limb Threatening Ischaemia Patients with Long Femoropopliteal Lesions.
    Zlatanovic P, Mahmoud AA, Cinara I, Cvetic V, Lukic B, Davidovic L.
    Eur J Vasc Endovasc Surg; 2021 Feb; 61(2):258-269. PubMed ID: 33334672
    [Abstract] [Full Text] [Related]

  • 12. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial.
    Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, Raab G, Ruckley CV.
    Health Technol Assess; 2010 Mar; 14(14):1-210, iii-iv. PubMed ID: 20307380
    [Abstract] [Full Text] [Related]

  • 13. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.
    Hsu CC, Kwan GN, Singh D, Rophael JA, Anthony C, van Driel ML.
    Cochrane Database Syst Rev; 2018 Dec 08; 12(12):CD009195. PubMed ID: 30536919
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Outcomes Following Infrapopliteal Plain Balloon Angioplasty in the BASIL Trial (1999-2004) and in a Contemporary Series (2009-2013).
    Popplewell MA, Davies HOB, Renton M, Bate G, Patel S, Deeks JJ, Bradbury AW.
    Vasc Endovascular Surg; 2020 Feb 08; 54(2):141-146. PubMed ID: 31749415
    [Abstract] [Full Text] [Related]

  • 15. BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial.
    Hunt BD, Popplewell MA, Davies H, Meecham L, Jarrett H, Bate G, Grant M, Patel S, Hewitt C, Andronis L, Deeks JJ, Bradbury A, BASIL-3 Collaborative Group.
    Trials; 2017 May 19; 18(1):224. PubMed ID: 28526046
    [Abstract] [Full Text] [Related]

  • 16. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.
    Bradbury AW, Moakes CA, Popplewell M, Meecham L, Bate GR, Kelly L, Chetter I, Diamantopoulos A, Ganeshan A, Hall J, Hobbs S, Houlind K, Jarrett H, Lockyer S, Malmstedt J, Patel JV, Patel S, Rashid ST, Saratzis A, Slinn G, Scott DJA, Zayed H, Deeks JJ, BASIL-2 Investigators.
    Lancet; 2023 May 27; 401(10390):1798-1809. PubMed ID: 37116524
    [Abstract] [Full Text] [Related]

  • 17. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy.
    Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, Ruckley CV, Raab GM, BASIL trial Participants.
    J Vasc Surg; 2010 May 27; 51(5 Suppl):5S-17S. PubMed ID: 20435258
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Procedural and 12-month in-hospital costs of primary infra-popliteal bypass surgery, infrapopliteal best endovascular treatment, and major lower limb amputation for chronic limb threatening ischemia.
    Popplewell MA, Andronis L, Davies HOB, Meecham L, Kelly L, Bate G, Bradbury AW.
    J Vasc Surg; 2022 Jan 27; 75(1):195-204. PubMed ID: 34481898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.